Filing Flows › Celularity (CELU) › Q4 2025
Celularity (CELU) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Apr 30, 2026
Celularity (CELU) reported revenue of $4.1M for the fourth quarter 2025 (Q4 2025), -77% from a year earlier and -22% from the quarter before. Operating margin was -537.5%, net loss $24.4M (593.6% of revenue).
Celularity, Q4 2025: revenue $4.1M (-77% year over year), operating margin -537.5%, net loss $24.4M, operating cash flow −$5.1M. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.1M | -22% | -77% |
| Operating profit | −$22.1M | — | — |
| Net earnings | −$24.4M | — | — |
| Operating cash flow | −$5.1M | — | -420% |
What changed
Revenue was $4.1M in Q4 2025, down 77% year over year and down 22% from the previous quarter. License Royalty and Other was the largest line at 47% of revenue.
Operating costs exceeded revenue by $22.1M, an operating margin of -537.5%. Total costs fell 5% while revenue fell 77%. The fastest-growing cost line was Other operating costs (+106%). The quarter ended with a net loss of $24.4M, wider than the previous quarter's $23.1M loss.
Operating cash flow was −$5.1M. Non-cash charges added back $1.8M of depreciation and amortization and $3.5M of share-based compensation. Working capital and other items added $13.9M.
Questions
What was Celularity's revenue in the fourth quarter 2025?
Celularity (CELU) reported revenue of $4.1M for the fourth quarter 2025 (Q4 2025), -77% from a year earlier and -22% from the quarter before.
Was Celularity profitable in the fourth quarter 2025?
Operating loss was $22.1M (-537.5% of revenue) and net loss $24.4M.
Source: Celularity 10-K on SEC EDGAR.